Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001437749-25-008989
Filing Date
2025-03-24
Accepted
2025-03-24 16:50:19
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM S-3 clnn20240815_s3.htm S-3 381188
2 EXHIBIT 5.1 ex_715566.htm EX-5.1 50076
3 EXHIBIT 23.2 ex_715567.htm EX-23.2 2512
4 EXHIBIT 107 ex_717302.htm EX-FILING FEES 21076
5 clenelogo11percent.jpg GRAPHIC 10252
6 hklogo35px.jpg GRAPHIC 8086
7 pipelinejan2025_22pct.jpg GRAPHIC 109216
  Complete submission text file 0001437749-25-008989.txt   631985
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

EIN.: 852828339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-286058 | Film No.: 25764802
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)